Accessibility Menu
 
Surgery Partners logo

Surgery Partners

(NASDAQ) SGRY

Current Price$11.52
Market Cap$1.49B
Since IPO (2015)-38%
5 Year-74%
1 Year-52%
1 Month-26%

Surgery Partners Financials at a Glance

Market Cap

$1.49B

Revenue (TTM)

$3.31B

Net Income (TTM)

$77.90M

EPS (TTM)

$-0.61

P/E Ratio

-18.74

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Price

$11.52

Volume

17,236

Open

$11.74

Previous Close

$11.52

Daily Range

$11.46 - $11.83

52-Week Range

$11.45 - $24.18

SGRY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgery Partners

Industry

Healthcare Providers and Services

Employees

16,000

CEO

J. Eric Evans, MBA

Headquarters

Brentwood, TN 37027, US

SGRY Financials

Key Financial Metrics (TTM)

Gross Margin

23%

Operating Margin

12%

Net Income Margin

-2%

Return on Equity

-4%

Return on Capital

5%

Return on Assets

-1%

Earnings Yield

-5.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.49B

Shares Outstanding

129.42M

Volume

17.24K

Short Interest

0.00%

Avg. Volume

1.66M

Financials (TTM)

Gross Profit

$765.00M

Operating Income

$389.50M

EBITDA

$565.50M

Operating Cash Flow

$274.30M

Capital Expenditure

$78.70M

Free Cash Flow

$195.60M

Cash & ST Invst.

$239.90M

Total Debt

$4.02B

Surgery Partners Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$885.00M

+2.4%

Gross Profit

$212.20M

-9.2%

Gross Margin

23.98%

N/A

Market Cap

$1.49B

N/A

Market Cap/Employee

$99.14K

N/A

Employees

15,000

N/A

Net Income

$15.00M

+86.2%

EBITDA

$295.10M

+83.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.78B

-10.2%

Accounts Receivable

$602.20M

+4.0%

Inventory

$96.60M

+9.3%

Long Term Debt

$3.88B

+9.0%

Short Term Debt

$142.00M

-0.3%

Return on Assets

-0.95%

N/A

Return on Invested Capital

5.11%

N/A

Free Cash Flow

$90.60M

+1.7%

Operating Cash Flow

$103.40M

-7.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATECAlphatec Holdings, Inc.
$10.93-5.12%
ARDTArdent Health Partners, LLC
$8.59-2.16%
ZLABZai Lab Limited
$18.00+2.80%
HTFLHeartflow, Inc. Common Stock
$24.69-4.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About SGRY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.